Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
Cytomegalovirus: Antivirals and Immune Defense
Sunday August 03, 2025 - 16:30 to 17:45
Room: 4
4.2 Risk Factors and Real-World Implications of CMV Resistance Mutations After Treatment with Maribavir or Foscarnet for Resistant and Refractory CMV
Log in to add to favorites
Add Personal Notes
Chelsea Morinishi, United States
Presentations by Chelsea Morinishi
Sun-03 from 16:30 - 17:45 in room 4
Cytomegalovirus: Antivirals and Immune Defense
Risk Factors and Real-World Implications of CMV Resistance Mutations After Treatment with Maribavir or Foscarnet for Resistant and Refractory CMV
Email:
info@wtc2025.org
514-874-1717